Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Sala

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Haematologica|March 28, 2008
Characterization of compound 584, an Abl kinase inhibitor with lasting effectsMiriam Puttini, Sara Redaelli, Loris Moretti, et al.
Frontiers in Immunology|May 19, 2023
Risk factors and characteristics influencing humoral response to COVID-19 vaccination in patients after allogeneic stem cell transplantationMarie Luise Hütter-Krönke, Adela Neagoie, Igor Wolfgang Blau, et al.
Journal of Medicinal Chemistry|February 11, 2010
Biological and biophysical properties of the histone deacetylase inhibitor suberoylanilide hydroxamic acid are affected by the presence of short alkyl groups on the phenyl ringFrédérik Oger, Aurélien Lecorgne, Elisa Sala, et al.
Frontiers in Endocrinology|July 11, 2022
A Multicenter Cohort Study in Patients With Primary Empty Sella: Hormonal and Neuroradiological Features Over a Long Follow-UpGiulia Carosi, Alessandro Brunetti, Alessandra Mangone, et al.
Frontiers in Immunology|December 31, 2021
<i>HLA-DRB3/4/5</i> Matching Improves Outcome of Unrelated Hematopoietic Stem Cell TransplantationChrysanthi Tsamadou, Daphne Engelhardt, Uwe Platzbecker, et al.
Haematologica|March 5, 2026
Impact of FMS-like tyrosine kinase 3 inhibitor maintenance on post-transplant outcomes in acute myeloid leukemia with FMS-like tyrosine kinase 3 mutations: a real-world German registry analysis highlighting sorafenibRadwan Massoud, Sarah Flossdorf, Franziska Hanke, et al.
Bone Marrow Transplantation|April 8, 2026
Haploidentical transplantation with post-transplant cyclophosphamide is not inferior to 9/10-MUD transplantation with ATG in patients with myeloid malignanciesAndrea Gantner, Svenja Labuhn, Daniel Fürst, et al.
Bone Marrow Transplantation|July 8, 2022
Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantationChrysanthi Tsamadou, Sowmya Gowdavally, Uwe Platzbecker, et al.
Blood Advances|October 5, 2024
Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in GermanyAysenur Arslan, Svenja Labuhn, Elisa Sala, et al.
HLA|July 8, 2022
Higher risk for chronic graft-versus-host disease (GvHD) in HLA-G mismatched transplants following allogeneic hematopoietic stem cell transplantation: A retrospective studyChristine Neuchel, Sowmya Gowdavally, Chrysanthi Tsamadou, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Haematologica|March 28, 2008
Characterization of compound 584, an Abl kinase inhibitor with lasting effectsMiriam Puttini, Sara Redaelli, Loris Moretti, et al.
Frontiers in Immunology|May 19, 2023
Risk factors and characteristics influencing humoral response to COVID-19 vaccination in patients after allogeneic stem cell transplantationMarie Luise Hütter-Krönke, Adela Neagoie, Igor Wolfgang Blau, et al.
Journal of Medicinal Chemistry|February 11, 2010
Biological and biophysical properties of the histone deacetylase inhibitor suberoylanilide hydroxamic acid are affected by the presence of short alkyl groups on the phenyl ringFrédérik Oger, Aurélien Lecorgne, Elisa Sala, et al.
Frontiers in Endocrinology|July 11, 2022
A Multicenter Cohort Study in Patients With Primary Empty Sella: Hormonal and Neuroradiological Features Over a Long Follow-UpGiulia Carosi, Alessandro Brunetti, Alessandra Mangone, et al.
Frontiers in Immunology|December 31, 2021
<i>HLA-DRB3/4/5</i> Matching Improves Outcome of Unrelated Hematopoietic Stem Cell TransplantationChrysanthi Tsamadou, Daphne Engelhardt, Uwe Platzbecker, et al.
Haematologica|March 5, 2026
Impact of FMS-like tyrosine kinase 3 inhibitor maintenance on post-transplant outcomes in acute myeloid leukemia with FMS-like tyrosine kinase 3 mutations: a real-world German registry analysis highlighting sorafenibRadwan Massoud, Sarah Flossdorf, Franziska Hanke, et al.
Bone Marrow Transplantation|April 8, 2026
Haploidentical transplantation with post-transplant cyclophosphamide is not inferior to 9/10-MUD transplantation with ATG in patients with myeloid malignanciesAndrea Gantner, Svenja Labuhn, Daniel Fürst, et al.
Bone Marrow Transplantation|July 8, 2022
Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantationChrysanthi Tsamadou, Sowmya Gowdavally, Uwe Platzbecker, et al.
Blood Advances|October 5, 2024
Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in GermanyAysenur Arslan, Svenja Labuhn, Elisa Sala, et al.
HLA|July 8, 2022
Higher risk for chronic graft-versus-host disease (GvHD) in HLA-G mismatched transplants following allogeneic hematopoietic stem cell transplantation: A retrospective studyChristine Neuchel, Sowmya Gowdavally, Chrysanthi Tsamadou, et al.
Pageof 9